Type 2 Diabetes Mellitus Clinical Trial
Official title:
Effect of Holistic Management on the Patients With Type 2 Diabetes Who Received or Did Not Receive a Short-term Intensive Education
Two hundreds patients with T2DM from the outpatient clinic of The First Affiliated Hospital
of Chongqing Medical University will be enrolled in this study. Participating subjects will
be randomly assigned into one of the 2 groups: Group A (n=100) will be placed on the
short-term intensive education program alone while Group B (n=100) will be placed on the
short-term intensive education as well as a holistic management for 6 months.
Diabetes education: The patients of each group will undergo designated education programs in
4 subgroups. Group A and B will be given the same education classes once a week in the first
month (total 4 times), 5 hours per class. The education classes will be taught by a dedicated
team of diabetes specialist doctors and nurses, with the contents including a basic
understanding of diabetes, diabetic diet, exercise, drug treatments and blood glucose
monitoring. At the conclusion of the education classes, the patients in Group B then will
undergo a weekly telephone interview with specialist nurses for 6 months to help patients
resolve self-management problems while patients in Group A will not. The specialist nurses
will talk individually with the patients in Group B for 10-15 min per week. The nurses will
ask the patients about their results of self-blood glucose monitoring, help them find the
reasons of poor blood glucose control as well as answer the patient's questions.
Clinical examination: All subjects will complete Audit of Diabetes Dependent Quality of Life
(ADDQoL) before education classes commence (baseline), at 3 months and 6 months (endpoint)
after education classes to evaluate their quality of life. All patients will be examined for
height, weight, blood pressure, FPG, PPG and HbA1c at baseline, 3 months after education
classes and endpoint. A diabetes specialist nurse will measure the height, weight and blood
pressure, and assist the subjects to fill the questionnaire. FPG and PPG will be determined
by the hexokinase method, while HbA1c by high performance liquid chromatography.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02252224 -
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance
|